KELONIA THERAPEUTICS
Kelonia Therapeutics is developing a new wave of genetic medicines using its next generation vivo gene delivery platform.
KELONIA THERAPEUTICS
Industry:
Biotechnology Genetics Health Care Medical Therapeutics
Founded:
2017-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.keloniatx.com
Total Employee:
11+
Status:
Active
Total Funding:
50 M USD
Current Employees Featured
Investors List
Alta Partners
Alta Partners investment in Series A - Kelonia Therapeutics
Venrock
Venrock investment in Series A - Kelonia Therapeutics
Horizons Ventures
Horizons Ventures investment in Series A - Kelonia Therapeutics
Official Site Inspections
http://www.keloniatx.com Semrush global rank: 5 M Semrush visits lastest month: 1.68 K
- Host name: 151.101.130.159
- IP address: 151.101.130.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Kelonia Therapeutics"
About Us | kelonia | Delivering on the Promise of …
Kristen Hege, M.D. Former SVP of Early Clinical Development, Hematology/Oncology & Cell TherapySee details»
Kelonia Therapeutics - LinkedIn
Kelonia is pioneering a new wave of genetic medicines using its next generation gene delivery platform. The company’s simple and elegant cutting-edge in vivo gene delivery technology uses a few ...See details»
Kelonia Therapeutics - Overview, News & Similar companies
Jun 20, 2024 View Kelonia Therapeutics (www.keloniatx.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Careers | kelonia | Delivering on the Promise of Genetic Medicine
Benefits. We care about our people, and our goal is for our benefits package to reflect that. Highlights of our current offering include: A robust health insurance package: medical, dental, …See details»
Kelonia Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Keloniatx.com. Startups | Holding Company | 2017 | Massachusetts, United States | 10-50 | keloniatx.com. Last update 08 Mar 2025. Overview. Pipeline. Deal. Translational Medicine. ...See details»
Kelonia Therapeutics - LifeScienceHistory.com
Keloniatx.com. 5 Channel Center St 4th Floor. Boston, MA 2210. Company Info Year Established 2017. Contacts Kevin Friedman, Ph.D. Founder & CEO Ryan Lynch VP, Finance Bharat …See details»
Kelonia Therapeutics - Work in biotech
Kelonia Therapeutics develops genetic medicines for a variety of diseases. They are developing a unique gene delivery approach that uses lentiviral vector-like particles to deliver genetic cargo …See details»
Kelonia Therapeutics - Crunchbase Company Profile
Kelonia Therapeutics is developing a new wave of genetic medicines using its next-generation vivo gene delivery platform. The company's cutting-edge in vivo gene delivery technology is simple and elegant, relying on a few potent …See details»
About KELONIA THERAPEUTICS | DxMultiomics
Keloniatx.com. Mark. Kelonia is pioneering a new wave of genetic medicines using its in vivo gene placement system (iGPS®). The company's elegant, cutting-edge in vivo gene delivery …See details»
Kelonia Therapeutics Launches with $50 Million Series A Financing …
Apr 28, 2022 With an initial focus on developing transformational therapies for solid tumors and hematologic cancers, Kelonia is building a pipeline of genetic medicines for a wide range of …See details»
Kelonia Therapeutics - VentureRadar
Kelonia’s technology will unlock the full promise of genetic medicine by overcoming the central challenge that is shared across all existing... ... Find out more ...See details»
Kelonia Therapeutics CEO and Key Executive Team | Craft.co
Kelonia Therapeutics's Chief Executive Officer, Founder is Kevin Friedman. Other executives include Travis Quigley, Senior Vice President – Clinical Development; Ryan Lynch, Vice …See details»
Astellas and Kelonia Therapeutics Enter into Research and License ...
Feb 15, 2024 Kelonia is a biotech company pioneering a new wave of genetic medicines using its in vivo gene placement system (iGPS ®). iGPS ® uses next generation lentiviral particles to …See details»
Kelonia Therapeutics, Inc. (Kelonia Therapeutics, Inc.) - 药物管线_ …
了解Kelonia Therapeutics, Inc. (Kelonia Therapeutics, Inc.)公司的药物管线，治疗领域，技术平台，以及它的24篇新闻，疾病领域:血液及淋巴系统疾病，肿瘤，免疫系统疾病，技术平台:自 …See details»
Astellas and Kelonia Therapeutics Enter into Research and License ...
Feb 15, 2024 Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Kelonia Therapeutics (CEO, Founder: Kevin Friedman, Ph.D., "Kelonia") today …See details»
Our Therapeutic Focus - Kelonia
Press play below to learn how kelonia’s revolutionary iGPS® technology makes CAR T therapies available to patients when and where they need them.See details»
Astellas and Kelonia Therapeutics Enter into Research and License ...
Feb 15, 2024 Innovative universal, off-the-shelf in vivo CAR-T Cell therapy. TOKYO and BOSTON, Feb. 15, 2024 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and …See details»
News & Press Releases | kelonia | Promise of Genetic Medicine
Explore our latest news, press releases, and events as we develop a new wave of accessible genetic medicines that will transform the lives of patients.See details»
Delivering on the Promise of Genetic Medicine - Kelonia
IGPS® technology is built on a well-understood gene delivery system . kelonia's iGPS® technology is built on a lentiviral vector (LVV) engineered with a targeting molecule that …See details»